Quarterly Result25 Feb 2026, 07:13 pm
Sanofi Consumer Healthcare India Ltd Approves Audited Financial Statements for FY2025, Recommends Dividend
AI Summary
Sanofi Consumer Healthcare India Ltd's Board of Directors approved the audited standalone financial statements for the quarter and financial year ended 31st December 2025. The company recommended a final dividend of Rs. 75/- per equity share for the FY ended 31st December 2025, subject to approval by shareholders at the ensuing Annual General Meeting (AGM).
Key Highlights
- Sanofi Consumer Healthcare India Ltd approved the audited standalone financial statements for Q4 and FY2025.
- The company recommended a final dividend of Rs. 75/- per equity share for the FY ended 31st December 2025.
- The dividend recommendation is subject to approval by shareholders at the ensuing AGM.